glp 1 before and after 2 months Weight loss with Semaglutide & Phentermine GLP-1 Weight Loss Program |

7 Comparison with other drugs Some clinical studies have used other metabolic medications and compared their effects on liver diseases to those of GLP-1RAs

In 2017, the Food and Drug Administration (FDA) approved Ozempic, which contains semaglutide as the main active ingredient, as a treatment for type 2 diabetes

GLP-1 oral liquid formulations require specific administration protocols to achieve therapeutic results in 2026, including fasting windows, food timing, and individual absorption variables

Important safety considerations include: Hypoglycaemia risk increases when Ozempic is used in combination with insulin or sulphonylureas

Anatomical abnormalities : Pancreatic duct abnormalities or pancreas divisum may increase susceptibility